Press Releases

“Super-utilizers,” meaning patients with complex health issues and frequent hospital visits, are becoming a focus of care management programs in an effort to improve patient outcomes. A study published in The American Journal of Managed Care®, and featured on our next Managed Care Cast podcast, found that Medicare fee-for-service patients in four states who fit this category and were enrolled in a high-intensity care management program had 37 percent fewer unplanned hospital readmissions.

Randomized controlled trials don’t capture real-world evidence regarding how patients will actually interact with, adhere to, or find value in a costly new medical therapy, and current value frameworks and assessments don’t include this “real world” element. In the current issue of The American Journal of Managed Care®, authors offer guidance on closing the gap between real-world and clinical trial data when formulating value frameworks.

Significant investments are needed in new comprehensive data networks that connect and integrate clinical factors, social determinants of health, and genomic information from multiple health systems in order to improve care for high-need, high-cost patients, according to a commentary in The American Journal of Managed Care®. AJMC® interviewed one of the authors for additional details about this issue for a recent episode of Managed Care Cast, our podcast about managed care.

With the US population aging rapidly, payers, providers, and public policy makers are seeking ways to both improve quality of care and reduce rising costs. A new study in The American Journal of Managed Care® found that giving Medicare Advantage patients more frequent contact with their primary care doctors kept them healthier and cost 28 percent less than usual care.

An issue covering major clinical findings and managed care updates from the annual meeting of the American Society of Clinical Oncology is now available from Evidence-Based Oncology™, a publication of The American Journal of Managed Care®.

What seems like a straightforward idea—screen current and former heavy smokers for lung cancer—proves more challenging in practice, according to findings from a demonstration project at the Minneapolis Veterans Affairs Health Care System.

Researchers from the University of Maryland at Baltimore tracked how quickly drugs in eight therapeutic classes made it onto formulary across hundreds of Medicare Part D plans over five years, and found that while plan differences mattered, drug characteristics mattered more in decisions.

Brand Logo

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo